1. Home
  2. GDTC vs RVP Comparison

GDTC vs RVP Comparison

Compare GDTC & RVP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GDTC
  • RVP
  • Stock Information
  • Founded
  • GDTC 2018
  • RVP 1994
  • Country
  • GDTC Singapore
  • RVP United States
  • Employees
  • GDTC N/A
  • RVP N/A
  • Industry
  • GDTC Biotechnology: Pharmaceutical Preparations
  • RVP Medical/Dental Instruments
  • Sector
  • GDTC Health Care
  • RVP Health Care
  • Exchange
  • GDTC Nasdaq
  • RVP Nasdaq
  • Market Cap
  • GDTC 24.8M
  • RVP 29.2M
  • IPO Year
  • GDTC 2023
  • RVP 2001
  • Fundamental
  • Price
  • GDTC $1.95
  • RVP $0.82
  • Analyst Decision
  • GDTC
  • RVP
  • Analyst Count
  • GDTC 0
  • RVP 0
  • Target Price
  • GDTC N/A
  • RVP N/A
  • AVG Volume (30 Days)
  • GDTC 268.9K
  • RVP 229.2K
  • Earning Date
  • GDTC 01-01-0001
  • RVP 11-14-2025
  • Dividend Yield
  • GDTC N/A
  • RVP N/A
  • EPS Growth
  • GDTC N/A
  • RVP N/A
  • EPS
  • GDTC N/A
  • RVP N/A
  • Revenue
  • GDTC $573,193.00
  • RVP $38,161,712.00
  • Revenue This Year
  • GDTC $5.37
  • RVP N/A
  • Revenue Next Year
  • GDTC N/A
  • RVP N/A
  • P/E Ratio
  • GDTC N/A
  • RVP N/A
  • Revenue Growth
  • GDTC 63.03
  • RVP N/A
  • 52 Week Low
  • GDTC $1.65
  • RVP $0.56
  • 52 Week High
  • GDTC $4.05
  • RVP $1.14
  • Technical
  • Relative Strength Index (RSI)
  • GDTC 42.08
  • RVP 40.15
  • Support Level
  • GDTC $1.68
  • RVP $0.83
  • Resistance Level
  • GDTC $3.10
  • RVP $0.89
  • Average True Range (ATR)
  • GDTC 0.34
  • RVP 0.06
  • MACD
  • GDTC -0.06
  • RVP -0.02
  • Stochastic Oscillator
  • GDTC 13.50
  • RVP 6.61

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

About RVP Retractable Technologies Inc.

Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to the Company's other products.

Share on Social Networks: